• Home
  • Pharmaceuticals and Healthcare
Oral Transmucosal Drugs Market - Global Outlook and Forecast 2021-2027

Oral Transmucosal Drugs Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ833211 | No. of Pages: 107 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jul-2021 
This report contains market size and forecasts of Oral Transmucosal Drugs in global, including the following market information:
Global Oral Transmucosal Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Oral Transmucosal Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Oral Transmucosal Drugs companies in 2020 (%)
The global Oral Transmucosal Drugs market was valued at XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Transmucosal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Transmucosal Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, By Type, 2020 (%)
    Tablets
    Films
    Liquid Spray
    Gels
    Others

Global Oral Transmucosal Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, By Application, 2020 (%)
    Cardiovascular Disorders
    Acute Pain Managements
    Diabetes
    Others

Global Oral Transmucosal Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Transmucosal Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Oral Transmucosal Drugs revenues share in global market, 2020 (%)
Key companies Oral Transmucosal Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Oral Transmucosal Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    LTS Lohmann Therapie-Systeme AG
    Soligenix
    ZIM Laboratories Limited
    Access Pharmaceutical Inc.
    C.L Pharm
    Cure Pharmaceutical
    Aquestive Therapeutics, Inc.
    NAL Pharma
    IntelGenx Corp.
    Eisai Co., Ltd.
    Otsuka Pharmaceutical Co., Ltd.
    Teva Pharmaceutical Industries Ltd.
    GlaxoSmithKline plc
    Viatris
    Bristol-Myers Squibb Company
1 Introduction to Research & Analysis Reports
    1.1 Oral Transmucosal Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oral Transmucosal Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oral Transmucosal Drugs Overall Market Size
    2.1 Global Oral Transmucosal Drugs Market Size: 2021 VS 2027
    2.2 Global Oral Transmucosal Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Oral Transmucosal Drugs Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Oral Transmucosal Drugs Players in Global Market
    3.2 Top Global Oral Transmucosal Drugs Companies Ranked by Revenue
    3.3 Global Oral Transmucosal Drugs Revenue by Companies
    3.4 Global Oral Transmucosal Drugs Sales by Companies
    3.5 Global Oral Transmucosal Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Oral Transmucosal Drugs Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Oral Transmucosal Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Oral Transmucosal Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Oral Transmucosal Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Oral Transmucosal Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oral Transmucosal Drugs Market Size Markets, 2021 & 2027
        4.1.2 Tablets
        4.1.3 Films
        4.1.4 Liquid Spray
        4.1.5 Gels
        4.1.6 Others
    4.2 By Type - Global Oral Transmucosal Drugs Revenue & Forecasts
        4.2.1 By Type - Global Oral Transmucosal Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Oral Transmucosal Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Oral Transmucosal Drugs Revenue Market Share, 2016-2027
    4.3 By Type - Global Oral Transmucosal Drugs Sales & Forecasts
        4.3.1 By Type - Global Oral Transmucosal Drugs Sales, 2016-2021
        4.3.2 By Type - Global Oral Transmucosal Drugs Sales, 2022-2027
        4.3.3 By Type - Global Oral Transmucosal Drugs Sales Market Share, 2016-2027
    4.4 By Type - Global Oral Transmucosal Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oral Transmucosal Drugs Market Size, 2021 & 2027
        5.1.2 Cardiovascular Disorders
        5.1.3 Acute Pain Managements
        5.1.4 Diabetes
        5.1.5 Others
    5.2 By Application - Global Oral Transmucosal Drugs Revenue & Forecasts
        5.2.1 By Application - Global Oral Transmucosal Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Oral Transmucosal Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Oral Transmucosal Drugs Revenue Market Share, 2016-2027
    5.3 By Application - Global Oral Transmucosal Drugs Sales & Forecasts
        5.3.1 By Application - Global Oral Transmucosal Drugs Sales, 2016-2021
        5.3.2 By Application - Global Oral Transmucosal Drugs Sales, 2022-2027
        5.3.3 By Application - Global Oral Transmucosal Drugs Sales Market Share, 2016-2027
    5.4 By Application - Global Oral Transmucosal Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Oral Transmucosal Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Oral Transmucosal Drugs Revenue & Forecasts
        6.2.1 By Region - Global Oral Transmucosal Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Oral Transmucosal Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Oral Transmucosal Drugs Revenue Market Share, 2016-2027
    6.3 By Region - Global Oral Transmucosal Drugs Sales & Forecasts
        6.3.1 By Region - Global Oral Transmucosal Drugs Sales, 2016-2021
        6.3.2 By Region - Global Oral Transmucosal Drugs Sales, 2022-2027
        6.3.3 By Region - Global Oral Transmucosal Drugs Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Oral Transmucosal Drugs Revenue, 2016-2027
        6.4.2 By Country - North America Oral Transmucosal Drugs Sales, 2016-2027
        6.4.3 US Oral Transmucosal Drugs Market Size, 2016-2027
        6.4.4 Canada Oral Transmucosal Drugs Market Size, 2016-2027
        6.4.5 Mexico Oral Transmucosal Drugs Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Oral Transmucosal Drugs Revenue, 2016-2027
        6.5.2 By Country - Europe Oral Transmucosal Drugs Sales, 2016-2027
        6.5.3 Germany Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.4 France Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.5 U.K. Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.6 Italy Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.7 Russia Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.8 Nordic Countries Oral Transmucosal Drugs Market Size, 2016-2027
        6.5.9 Benelux Oral Transmucosal Drugs Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Oral Transmucosal Drugs Revenue, 2016-2027
        6.6.2 By Region - Asia Oral Transmucosal Drugs Sales, 2016-2027
        6.6.3 China Oral Transmucosal Drugs Market Size, 2016-2027
        6.6.4 Japan Oral Transmucosal Drugs Market Size, 2016-2027
        6.6.5 South Korea Oral Transmucosal Drugs Market Size, 2016-2027
        6.6.6 Southeast Asia Oral Transmucosal Drugs Market Size, 2016-2027
        6.6.7 India Oral Transmucosal Drugs Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Oral Transmucosal Drugs Revenue, 2016-2027
        6.7.2 By Country - South America Oral Transmucosal Drugs Sales, 2016-2027
        6.7.3 Brazil Oral Transmucosal Drugs Market Size, 2016-2027
        6.7.4 Argentina Oral Transmucosal Drugs Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Oral Transmucosal Drugs Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Oral Transmucosal Drugs Sales, 2016-2027
        6.8.3 Turkey Oral Transmucosal Drugs Market Size, 2016-2027
        6.8.4 Israel Oral Transmucosal Drugs Market Size, 2016-2027
        6.8.5 Saudi Arabia Oral Transmucosal Drugs Market Size, 2016-2027
        6.8.6 UAE Oral Transmucosal Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 LTS Lohmann Therapie-Systeme AG
        7.1.1 LTS Lohmann Therapie-Systeme AG Corporate Summary
        7.1.2 LTS Lohmann Therapie-Systeme AG Business Overview
        7.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Major Product Offerings
        7.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.1.5 LTS Lohmann Therapie-Systeme AG Key News
    7.2 Soligenix
        7.2.1 Soligenix Corporate Summary
        7.2.2 Soligenix Business Overview
        7.2.3 Soligenix Oral Transmucosal Drugs Major Product Offerings
        7.2.4 Soligenix Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.2.5 Soligenix Key News
    7.3 ZIM Laboratories Limited
        7.3.1 ZIM Laboratories Limited Corporate Summary
        7.3.2 ZIM Laboratories Limited Business Overview
        7.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Major Product Offerings
        7.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.3.5 ZIM Laboratories Limited Key News
    7.4 Access Pharmaceutical Inc.
        7.4.1 Access Pharmaceutical Inc. Corporate Summary
        7.4.2 Access Pharmaceutical Inc. Business Overview
        7.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Major Product Offerings
        7.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.4.5 Access Pharmaceutical Inc. Key News
    7.5 C.L Pharm
        7.5.1 C.L Pharm Corporate Summary
        7.5.2 C.L Pharm Business Overview
        7.5.3 C.L Pharm Oral Transmucosal Drugs Major Product Offerings
        7.5.4 C.L Pharm Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.5.5 C.L Pharm Key News
    7.6 Cure Pharmaceutical
        7.6.1 Cure Pharmaceutical Corporate Summary
        7.6.2 Cure Pharmaceutical Business Overview
        7.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Major Product Offerings
        7.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.6.5 Cure Pharmaceutical Key News
    7.7 Aquestive Therapeutics, Inc.
        7.7.1 Aquestive Therapeutics, Inc. Corporate Summary
        7.7.2 Aquestive Therapeutics, Inc. Business Overview
        7.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Major Product Offerings
        7.4.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.7.5 Aquestive Therapeutics, Inc. Key News
    7.8 NAL Pharma
        7.8.1 NAL Pharma Corporate Summary
        7.8.2 NAL Pharma Business Overview
        7.8.3 NAL Pharma Oral Transmucosal Drugs Major Product Offerings
        7.8.4 NAL Pharma Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.8.5 NAL Pharma Key News
    7.9 IntelGenx Corp.
        7.9.1 IntelGenx Corp. Corporate Summary
        7.9.2 IntelGenx Corp. Business Overview
        7.9.3 IntelGenx Corp. Oral Transmucosal Drugs Major Product Offerings
        7.9.4 IntelGenx Corp. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.9.5 IntelGenx Corp. Key News
    7.10 Eisai Co., Ltd.
        7.10.1 Eisai Co., Ltd. Corporate Summary
        7.10.2 Eisai Co., Ltd. Business Overview
        7.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Major Product Offerings
        7.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.10.5 Eisai Co., Ltd. Key News
    7.11 Otsuka Pharmaceutical Co., Ltd.
        7.11.1 Otsuka Pharmaceutical Co., Ltd. Corporate Summary
        7.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Business Overview
        7.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Major Product Offerings
        7.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.11.5 Otsuka Pharmaceutical Co., Ltd. Key News
    7.12 Teva Pharmaceutical Industries Ltd.
        7.12.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Business Overview
        7.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Major Product Offerings
        7.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.12.5 Teva Pharmaceutical Industries Ltd. Key News
    7.13 GlaxoSmithKline plc
        7.13.1 GlaxoSmithKline plc Corporate Summary
        7.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Business Overview
        7.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Major Product Offerings
        7.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.13.5 GlaxoSmithKline plc Key News
    7.14 Viatris
        7.14.1 Viatris Corporate Summary
        7.14.2 Viatris Business Overview
        7.14.3 Viatris Oral Transmucosal Drugs Major Product Offerings
        7.14.4 Viatris Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.14.5 Viatris Key News
    7.15 Bristol-Myers Squibb Company
        7.15.1 Bristol-Myers Squibb Company Corporate Summary
        7.15.2 Bristol-Myers Squibb Company Business Overview
        7.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Major Product Offerings
        7.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales and Revenue in Global (2016-2021)
        7.15.5 Bristol-Myers Squibb Company Key News
8 Global Oral Transmucosal Drugs Production Capacity, Analysis
    8.1 Global Oral Transmucosal Drugs Production Capacity, 2016-2027
    8.2 Oral Transmucosal Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Oral Transmucosal Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Oral Transmucosal Drugs Supply Chain Analysis
    10.1 Oral Transmucosal Drugs Industry Value Chain
    10.2 Oral Transmucosal Drugs Upstream Market
    10.3 Oral Transmucosal Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Oral Transmucosal Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com